What insurance policy changes affect code Z30.2?

There are 4 tracked policy changes affecting code Z30.2, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code Z30.2?

Payers that have issued tracked updates for code Z30.2 include: Aetna.

How do I get notified when code Z30.2 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code Z30.2. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code Z30.2?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

Z30.2 Insurance Policy Changes

ICD-10 Z30.2 is officially defined as "Encounter for sterilization." code Z30.2 is referenced in 4 tracked payer policy changes from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code Z30.2 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Oct 13, 2026Medium impact
Tubal Sterilization (CPB 0657, reviewed 2026-10-07)
Aetna considers electrocoagulation, the Falope ring, the Filshie clip, the Hulka-Clemens clip, partial salpingectomy (Pomeroy and Parkland techniques) and total salpingectomy medically necessary for tubal sterilization. Aetna considers hysteroscopic tubal sterilization, including the Essure Micro-Insert, and the FemBloc permanent contraceptive system experimental, investigational, or unproven because their safety and long-term effects have not been established. CPT codes 58340, 58600, 58605, 58611, 58615, 58661, 58670, 58671, 58700 and 74740 are covered when selection criteria are met.
Aetna · Identified Aug 19, 2026Medium impact
Vasectomy Procedures and Chronic Scrotal Content Pain (CPB 0027, reviewed 2026-01-27)
Aetna Clinical Policy Bulletin 0027 considers vasectomy reversal medically necessary for post-vasectomy pain syndrome when the member has failed nonsteroidal anti-inflammatory medications and local nerve blocks or steroid injections. It considers microsurgical denervation of the spermatic cord medically necessary for chronic scrotal content pain when localized scrotal pain has persisted for 3 months or longer, conservative treatments have failed, and the member has a positive response to a spermatic cord block of 50% or greater pain reduction. Endoscopic vasectomy, the Vasclip implantable clip, the Pro-Vas occlusion method, vasal injection, vasal occlusion and epididymectomy for post-vasectomy pain are listed as experimental, investigational or unproven.
Aetna · Identified Aug 18, 2026Medium impact
Tubal Sterilization (CPB 0657, reviewed 2025-12-08)
Aetna considers electrocoagulation, the Falope ring, the Filshie clip, the Hulka-Clemens clip, partial salpingectomy (Pomeroy and Parkland techniques) and total salpingectomy medically necessary for tubal sterilization. Hysteroscopic tubal sterilization, such as the Essure Micro-Insert, and the FemBloc permanent contraceptive system are considered experimental, investigational, or unproven for birth control and all other indications because their safety and long-term effects have not been established. The manufacturer (Hologic) has discontinued production of the Adiana Permanent Contraception System.
Aetna · Identified Aug 14, 2026Medium impact
Endometrial Ablation (CPB 0091, reviewed 2026-03-25)
Aetna considers endometrial ablation medically necessary for women with menorrhagia that is unresponsive to, or has a contraindication to, either dilation and curettage or hormonal therapy, when the severity and persistence of the bleeding would otherwise make the member a candidate for hysterectomy. The selection criteria also require that endometrial sampling or D&C was performed on the same day or within the year before the procedure to exclude cancer, pre-cancer or hyperplasia, that structural abnormalities requiring surgery were excluded, and that a Pap smear and gynecologic examination excluded significant cervical disease. Aetna considers endometrial ablation experimental, investigational, or unproven for all other indications, such as post-menopausal bleeding.

Watch Z30.2

Get one email when a payer policy names Z30.2, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Tubal Sterilization (CPB 0657, reviewed 2026-10-07)

Vasectomy Procedures and Chronic Scrotal Content Pain (CPB 0027, reviewed 2026-01-27)

Tubal Sterilization (CPB 0657, reviewed 2025-12-08)

Endometrial Ablation (CPB 0091, reviewed 2026-03-25)

What insurance policy changes affect code Z30.2?

Which payers have updated policy for code Z30.2?

How do I get notified when code Z30.2 policy changes?

Why do payers change policies for code Z30.2?